Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$PVSP, Psilocybin play. Last trade .0035. DD: https://privateequitymarkets.us/newsletter/press-release-pervasip-corp-announces-development-for-kaiyon-biotech
$PVSP, Psilocybin play trading at .0035. .05 per share coming. Read last week's news: https://privateequitymarkets.us/newsletter/press-release-pervasip-corp-announces-development-for-kaiyon-biotech
Here to Serve Holding Corp. Acquires 15% Ownership in Kaiyon Biotech Inc., a Psilocybin Biotech Company
HTSC
+8.62%
Newsfile Corp.
June 17, 2021·2 min read
HTSC
+8.62%
Rye Brook, New York--(Newsfile Corp. - June 17, 2021) - Here To Serve Holdings Corp. (OTC Pink: HTSC) (the "Company") is pleased to announce its wholly owned subsidiary, ICF Industries Inc., has purchased a 15% non-dilutive stake in Kaiyon Biotech Inc. ("Kaiyon"). Kaiyon is a company creating medicines using psilocybin to treat debilitating conditions.
According to Cesar Herrera, President of ICF Industries, "Kaiyon doctors are early recipients of KFDA approval to study psilocybin in South Korea. We believe the scientists, doctors and researchers involved in Kaiyon are amongst the best in the world and they will be studying at Kaiyon's Bio-lab. We cannot be happier with this arrangement between the Company, Kaiyon, and Pervasip Corp. We believe we have amassed a world-class group of professionals for studying the positive effects of psilocybin."
A royalty agreement is being negotiated by the team and will be announced shortly.
- ADVERTISEMENT -
About Here To Serve Holding Corp.
Here to Serve Holding Corp. is a holding company that hunts for undervalued assets and accepts shares of common stock as a fee for its corporate advisory, SEC compliance, consulting, and marketing services. Run by an experienced team of professionals with diverse backgrounds, the Company formed two wholly owned subsidiaries, ICF Industries Inc. and Fortune Nickel and Gold Inc. ICF provides the advisory services to other companies and Fortune is dedicated to the global acquisition, exploration, and development of mining properties in prolific jurisdictions. Fortune recently acquired mining projects known as the Gowan and Beck-Ottaway properties located in the Timmins mining camp in Ontario, Canada. The Timmins mining camp lies at the heart of the Abitibi greenstone belt, which contains some of the world's largest deposits of gold, silver, copper, zinc, nickel, platinum-group metals, and industrial minerals such as talc. Fortune believes its projects have substantial gold and nickel potential.
For more information:
Please call Investor Relations with any questions at 855-4NICKEL (855-464-2535) extension 1.
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/87925
Pervasip Corp. Cancels One Billion Shares of Common Stock
Granada Hills, California--(Newsfile Corp. - July 9, 2021) - Pervasip Corp. (OTC Pink: PVSP) (the "Company") announced today that it has completed the cancelation of one billion shares of common stock.
The Company had issued one billion shares in conjunction with the purchase of an entity known as Plaid Canary Corp. However, the purchase was rescinded and the certificate for one billion shares that had been printed was lost. Upon receipt of medallion guaranteed stock powers and indemnifications, the Company's transfer agent was able to cancel the one billion share certificate and remove it from the issued shares.
"We are pleased to see our outstanding common stock decrease by one billion shares, a reduction of almost 20%," said Paul Riss, the Chief Executive Officer of the Company. "We are eager to focus on the business going forward, our pending acquisition of Artizen, and the psilocybin and CBD research from our affiliate, Kaiyon Biotech Inc."
About Pervasip Corp.
Pervasip Corp. is a developer of companies and technologies in high-value emerging markets. It owns a minority position in Kaiyon Bioptech Inc., which focuses on CBD and psilocybin research, primarily in South Korea. Pervasip is currently pursuing the acquisition of Artizen Corporation, which generates revenues by providing leasing, licensing, management, staffing, and supplies to cannabis production facilities. Artizen specializes in commercial indoor growing, with state-of-the-art water filtration and heating systems and light technology that allows for high levels of photosynthetic energy. For more information please visit the website http://www.artizencannabis.com.
Please email Investor Relations with any questions at info@pervasip.net or call 855-464-2535 extension 1.
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements include those that use forward-looking terminology, such as the words "anticipate," "believe," "estimate," "expect," "intend," "may," "hope'" "project," "plan," "will," "shall," "should," and similar expressions, including when used in the negative. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Pervasip Corp. Cancels One Billion Shares of Common Stock
Granada Hills, California--(Newsfile Corp. - July 9, 2021) - Pervasip Corp. (OTC Pink: PVSP) (the "Company") announced today that it has completed the cancelation of one billion shares of common stock.
The Company had issued one billion shares in conjunction with the purchase of an entity known as Plaid Canary Corp. However, the purchase was rescinded and the certificate for one billion shares that had been printed was lost. Upon receipt of medallion guaranteed stock powers and indemnifications, the Company's transfer agent was able to cancel the one billion share certificate and remove it from the issued shares.
"We are pleased to see our outstanding common stock decrease by one billion shares, a reduction of almost 20%," said Paul Riss, the Chief Executive Officer of the Company. "We are eager to focus on the business going forward, our pending acquisition of Artizen, and the psilocybin and CBD research from our affiliate, Kaiyon Biotech Inc."
About Pervasip Corp.
Pervasip Corp. is a developer of companies and technologies in high-value emerging markets. It owns a minority position in Kaiyon Bioptech Inc., which focuses on CBD and psilocybin research, primarily in South Korea. Pervasip is currently pursuing the acquisition of Artizen Corporation, which generates revenues by providing leasing, licensing, management, staffing, and supplies to cannabis production facilities. Artizen specializes in commercial indoor growing, with state-of-the-art water filtration and heating systems and light technology that allows for high levels of photosynthetic energy. For more information please visit the website http://www.artizencannabis.com.
Please email Investor Relations with any questions at info@pervasip.net or call 855-464-2535 extension 1.
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements include those that use forward-looking terminology, such as the words "anticipate," "believe," "estimate," "expect," "intend," "may," "hope'" "project," "plan," "will," "shall," "should," and similar expressions, including when used in the negative. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
info
$PVSP, Psilocybin play with BIG NEWS today! Looking for a PT of .05. Last trade .0038. Bottom buy. DD: https://www.privateequitymarkets.us/pervasip-corp-otcpvsp
$PVSP, Psilocybin play with BIG NEWS today! Looking for a PT of .05. Last trade .0038. Bottom buy. DD: https://www.privateequitymarkets.us/pervasip-corp-otcpvsp
$PVSP, Psilocybin play with BIG NEWS today! Looking for a PT of .05. Last trade .0038. Bottom buy. DD: https://www.privateequitymarkets.us/pervasip-corp-otcpvsp
Two NEW SHROOMBOOM Stocks: $HTSC @ .1166, $PVSP @ .0042
Here to Serve Holding Corp. Acquires 15% Ownership in Kaiyon Biotech Inc., a Psilocybin Biotech Company
Press Release | 06/17/2021
Rye Brook, New York--(Newsfile Corp. - June 17, 2021) - Here To Serve Holdings Corp. (OTC Pink: HTSC) (the "Company") is pleased to announce its wholly owned subsidiary, ICF Industries Inc., has purchased a 15% non-dilutive stake in Kaiyon Biotech Inc. ("Kaiyon"). Kaiyon is a company creating medicines using psilocybin to treat debilitating conditions.
According to Cesar Herrera, President of ICF Industries, "Kaiyon doctors are early recipients of KFDA approval to study psilocybin in South Korea. We believe the scientists, doctors and researchers involved in Kaiyon are amongst the best in the world and they will be studying at Kaiyon's Bio-lab. We cannot be happier with this arrangement between the Company, Kaiyon, and Pervasip Corp. We believe we have amassed a world-class group of professionals for studying the positive effects of psilocybin."
A royalty agreement is being negotiated by the team and will be announced shortly.
About Here To Serve Holding Corp.
Here to Serve Holding Corp. is a holding company that hunts for undervalued assets and accepts shares of common stock as a fee for its corporate advisory, SEC compliance, consulting, and marketing services. Run by an experienced team of professionals with diverse backgrounds, the Company formed two wholly owned subsidiaries, ICF Industries Inc. and Fortune Nickel and Gold Inc. ICF provides the advisory services to other companies and Fortune is dedicated to the global acquisition, exploration, and development of mining properties in prolific jurisdictions. Fortune recently acquired mining projects known as the Gowan and Beck-Ottaway properties located in the Timmins mining camp in Ontario, Canada. The Timmins mining camp lies at the heart of the Abitibi greenstone belt, which contains some of the world's largest deposits of gold, silver, copper, zinc, nickel, platinum-group metals, and industrial minerals such as talc. Fortune believes its projects have substantial gold and nickel potential.
For more information:
Please call Investor Relations with any questions at 855-4NICKEL (855-464-2535) extension 1.
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Pervasip Corp. Purchases Five Percent Interest in Kaiyon Biotech Inc.
Press Release | 06/16/2021
Granada Hills, California--(Newsfile Corp. - June 16, 2021) - Pervasip Corp. (OTC Pink: PVSP) (the "Company") is pleased to announce that it has purchased a five percent (5%) non-dilutive interest in Kaiyon Biotech Inc. ("Kaiyon").
Kaiyon is a collaboration of doctors, scientists, researchers and chemists that work to create new medicines using psilocybin and CBD compounds. The biotech team at Kaiyon believes that existing psilocybin research presents a pressing case for psilocybin to be an effective treatment for depression, pain, and drug addiction. It plans to expand on that research and support a hot bed of innovation for safe and productive drug use.
The Company applauds the newly formed Psilocybin Advisory Board formed in Oregon, and Oregon's efforts to build a support infrastructure through which psilocybin can be introduced to daily living via therapeutic use and licensed facilities.
The Company intends to leverage doctors and trained professionals in South Korea via its ownership in Kaiyon and bring the experience and training back to the United States. The acquisition requires the Company to issue 50 million restricted shares of common stock.
About Pervasip Corp.
Pervasip Corp. is a developer of companies and technologies in high value emerging markets. Pervasip is currently pursuing the acquisition of Artizen Corporation, which generates revenues by providing leasing, licensing, management, staffing, and supplies to cannabis production facilities.
Please email Investor Relations with any questions at info@pervasip.net or call 855-464-2535 extension 1.
Two NEW SHROOMBOOM Stocks: $HTSC @ .1166, $PVSP @ .0042
Here to Serve Holding Corp. Acquires 15% Ownership in Kaiyon Biotech Inc., a Psilocybin Biotech Company
Press Release | 06/17/2021
Rye Brook, New York--(Newsfile Corp. - June 17, 2021) - Here To Serve Holdings Corp. (OTC Pink: HTSC) (the "Company") is pleased to announce its wholly owned subsidiary, ICF Industries Inc., has purchased a 15% non-dilutive stake in Kaiyon Biotech Inc. ("Kaiyon"). Kaiyon is a company creating medicines using psilocybin to treat debilitating conditions.
According to Cesar Herrera, President of ICF Industries, "Kaiyon doctors are early recipients of KFDA approval to study psilocybin in South Korea. We believe the scientists, doctors and researchers involved in Kaiyon are amongst the best in the world and they will be studying at Kaiyon's Bio-lab. We cannot be happier with this arrangement between the Company, Kaiyon, and Pervasip Corp. We believe we have amassed a world-class group of professionals for studying the positive effects of psilocybin."
A royalty agreement is being negotiated by the team and will be announced shortly.
About Here To Serve Holding Corp.
Here to Serve Holding Corp. is a holding company that hunts for undervalued assets and accepts shares of common stock as a fee for its corporate advisory, SEC compliance, consulting, and marketing services. Run by an experienced team of professionals with diverse backgrounds, the Company formed two wholly owned subsidiaries, ICF Industries Inc. and Fortune Nickel and Gold Inc. ICF provides the advisory services to other companies and Fortune is dedicated to the global acquisition, exploration, and development of mining properties in prolific jurisdictions. Fortune recently acquired mining projects known as the Gowan and Beck-Ottaway properties located in the Timmins mining camp in Ontario, Canada. The Timmins mining camp lies at the heart of the Abitibi greenstone belt, which contains some of the world's largest deposits of gold, silver, copper, zinc, nickel, platinum-group metals, and industrial minerals such as talc. Fortune believes its projects have substantial gold and nickel potential.
For more information:
Please call Investor Relations with any questions at 855-4NICKEL (855-464-2535) extension 1.
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Pervasip Corp. Purchases Five Percent Interest in Kaiyon Biotech Inc.
Press Release | 06/16/2021
Granada Hills, California--(Newsfile Corp. - June 16, 2021) - Pervasip Corp. (OTC Pink: PVSP) (the "Company") is pleased to announce that it has purchased a five percent (5%) non-dilutive interest in Kaiyon Biotech Inc. ("Kaiyon").
Kaiyon is a collaboration of doctors, scientists, researchers and chemists that work to create new medicines using psilocybin and CBD compounds. The biotech team at Kaiyon believes that existing psilocybin research presents a pressing case for psilocybin to be an effective treatment for depression, pain, and drug addiction. It plans to expand on that research and support a hot bed of innovation for safe and productive drug use.
The Company applauds the newly formed Psilocybin Advisory Board formed in Oregon, and Oregon's efforts to build a support infrastructure through which psilocybin can be introduced to daily living via therapeutic use and licensed facilities.
The Company intends to leverage doctors and trained professionals in South Korea via its ownership in Kaiyon and bring the experience and training back to the United States. The acquisition requires the Company to issue 50 million restricted shares of common stock.
About Pervasip Corp.
Pervasip Corp. is a developer of companies and technologies in high value emerging markets. Pervasip is currently pursuing the acquisition of Artizen Corporation, which generates revenues by providing leasing, licensing, management, staffing, and supplies to cannabis production facilities.
Please email Investor Relations with any questions at info@pervasip.net or call 855-464-2535 extension 1.
Two NEW SHROOMBOOM Stocks: $HTSC @ .1166, $PVSP @ .0042
Here to Serve Holding Corp. Acquires 15% Ownership in Kaiyon Biotech Inc., a Psilocybin Biotech Company
Press Release | 06/17/2021
Rye Brook, New York--(Newsfile Corp. - June 17, 2021) - Here To Serve Holdings Corp. (OTC Pink: HTSC) (the "Company") is pleased to announce its wholly owned subsidiary, ICF Industries Inc., has purchased a 15% non-dilutive stake in Kaiyon Biotech Inc. ("Kaiyon"). Kaiyon is a company creating medicines using psilocybin to treat debilitating conditions.
According to Cesar Herrera, President of ICF Industries, "Kaiyon doctors are early recipients of KFDA approval to study psilocybin in South Korea. We believe the scientists, doctors and researchers involved in Kaiyon are amongst the best in the world and they will be studying at Kaiyon's Bio-lab. We cannot be happier with this arrangement between the Company, Kaiyon, and Pervasip Corp. We believe we have amassed a world-class group of professionals for studying the positive effects of psilocybin."
A royalty agreement is being negotiated by the team and will be announced shortly.
About Here To Serve Holding Corp.
Here to Serve Holding Corp. is a holding company that hunts for undervalued assets and accepts shares of common stock as a fee for its corporate advisory, SEC compliance, consulting, and marketing services. Run by an experienced team of professionals with diverse backgrounds, the Company formed two wholly owned subsidiaries, ICF Industries Inc. and Fortune Nickel and Gold Inc. ICF provides the advisory services to other companies and Fortune is dedicated to the global acquisition, exploration, and development of mining properties in prolific jurisdictions. Fortune recently acquired mining projects known as the Gowan and Beck-Ottaway properties located in the Timmins mining camp in Ontario, Canada. The Timmins mining camp lies at the heart of the Abitibi greenstone belt, which contains some of the world's largest deposits of gold, silver, copper, zinc, nickel, platinum-group metals, and industrial minerals such as talc. Fortune believes its projects have substantial gold and nickel potential.
For more information:
Please call Investor Relations with any questions at 855-4NICKEL (855-464-2535) extension 1.
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Pervasip Corp. Purchases Five Percent Interest in Kaiyon Biotech Inc.
Press Release | 06/16/2021
Granada Hills, California--(Newsfile Corp. - June 16, 2021) - Pervasip Corp. (OTC Pink: PVSP) (the "Company") is pleased to announce that it has purchased a five percent (5%) non-dilutive interest in Kaiyon Biotech Inc. ("Kaiyon").
Kaiyon is a collaboration of doctors, scientists, researchers and chemists that work to create new medicines using psilocybin and CBD compounds. The biotech team at Kaiyon believes that existing psilocybin research presents a pressing case for psilocybin to be an effective treatment for depression, pain, and drug addiction. It plans to expand on that research and support a hot bed of innovation for safe and productive drug use.
The Company applauds the newly formed Psilocybin Advisory Board formed in Oregon, and Oregon's efforts to build a support infrastructure through which psilocybin can be introduced to daily living via therapeutic use and licensed facilities.
The Company intends to leverage doctors and trained professionals in South Korea via its ownership in Kaiyon and bring the experience and training back to the United States. The acquisition requires the Company to issue 50 million restricted shares of common stock.
About Pervasip Corp.
Pervasip Corp. is a developer of companies and technologies in high value emerging markets. Pervasip is currently pursuing the acquisition of Artizen Corporation, which generates revenues by providing leasing, licensing, management, staffing, and supplies to cannabis production facilities.
Please email Investor Relations with any questions at info@pervasip.net or call 855-464-2535 extension 1.
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements include those that use forward-looking terminology, such as the words "anticipate," "believe," "estimate," "expect," "intend," "may," "hope'" "project," "plan," "will," "shall," "should," and similar expressions, including when used in the negative. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Two NEW SHROOMBOOM Stocks: $HTSC @ .1166, $PVSP @ .0042
Here to Serve Holding Corp. Acquires 15% Ownership in Kaiyon Biotech Inc., a Psilocybin Biotech Company
Press Release | 06/17/2021
Rye Brook, New York--(Newsfile Corp. - June 17, 2021) - Here To Serve Holdings Corp. (OTC Pink: HTSC) (the "Company") is pleased to announce its wholly owned subsidiary, ICF Industries Inc., has purchased a 15% non-dilutive stake in Kaiyon Biotech Inc. ("Kaiyon"). Kaiyon is a company creating medicines using psilocybin to treat debilitating conditions.
According to Cesar Herrera, President of ICF Industries, "Kaiyon doctors are early recipients of KFDA approval to study psilocybin in South Korea. We believe the scientists, doctors and researchers involved in Kaiyon are amongst the best in the world and they will be studying at Kaiyon's Bio-lab. We cannot be happier with this arrangement between the Company, Kaiyon, and Pervasip Corp. We believe we have amassed a world-class group of professionals for studying the positive effects of psilocybin."
A royalty agreement is being negotiated by the team and will be announced shortly.
About Here To Serve Holding Corp.
Here to Serve Holding Corp. is a holding company that hunts for undervalued assets and accepts shares of common stock as a fee for its corporate advisory, SEC compliance, consulting, and marketing services. Run by an experienced team of professionals with diverse backgrounds, the Company formed two wholly owned subsidiaries, ICF Industries Inc. and Fortune Nickel and Gold Inc. ICF provides the advisory services to other companies and Fortune is dedicated to the global acquisition, exploration, and development of mining properties in prolific jurisdictions. Fortune recently acquired mining projects known as the Gowan and Beck-Ottaway properties located in the Timmins mining camp in Ontario, Canada. The Timmins mining camp lies at the heart of the Abitibi greenstone belt, which contains some of the world's largest deposits of gold, silver, copper, zinc, nickel, platinum-group metals, and industrial minerals such as talc. Fortune believes its projects have substantial gold and nickel potential.
For more information:
Please call Investor Relations with any questions at 855-4NICKEL (855-464-2535) extension 1.
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Pervasip Corp. Purchases Five Percent Interest in Kaiyon Biotech Inc.
Press Release | 06/16/2021
Granada Hills, California--(Newsfile Corp. - June 16, 2021) - Pervasip Corp. (OTC Pink: PVSP) (the "Company") is pleased to announce that it has purchased a five percent (5%) non-dilutive interest in Kaiyon Biotech Inc. ("Kaiyon").
Kaiyon is a collaboration of doctors, scientists, researchers and chemists that work to create new medicines using psilocybin and CBD compounds. The biotech team at Kaiyon believes that existing psilocybin research presents a pressing case for psilocybin to be an effective treatment for depression, pain, and drug addiction. It plans to expand on that research and support a hot bed of innovation for safe and productive drug use.
The Company applauds the newly formed Psilocybin Advisory Board formed in Oregon, and Oregon's efforts to build a support infrastructure through which psilocybin can be introduced to daily living via therapeutic use and licensed facilities.
The Company intends to leverage doctors and trained professionals in South Korea via its ownership in Kaiyon and bring the experience and training back to the United States. The acquisition requires the Company to issue 50 million restricted shares of common stock.
About Pervasip Corp.
Pervasip Corp. is a developer of companies and technologies in high value emerging markets. Pervasip is currently pursuing the acquisition of Artizen Corporation, which generates revenues by providing leasing, licensing, management, staffing, and supplies to cannabis production facilities.
Please email Investor Relations with any questions at info@pervasip.net or call 855-464-2535 extension 1.
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements include those that use forward-looking terminology, such as the words "anticipate," "believe," "estimate," "expect," "intend," "may," "hope'" "project," "plan," "will," "shall," "should," and similar expressions, including when used in the negative. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Two NEW SHROOMBOOM Stocks: $HTSC @ .1166, $PVSP @ .0042
Here to Serve Holding Corp. Acquires 15% Ownership in Kaiyon Biotech Inc., a Psilocybin Biotech Company
Press Release | 06/17/2021
Rye Brook, New York--(Newsfile Corp. - June 17, 2021) - Here To Serve Holdings Corp. (OTC Pink: HTSC) (the "Company") is pleased to announce its wholly owned subsidiary, ICF Industries Inc., has purchased a 15% non-dilutive stake in Kaiyon Biotech Inc. ("Kaiyon"). Kaiyon is a company creating medicines using psilocybin to treat debilitating conditions.
According to Cesar Herrera, President of ICF Industries, "Kaiyon doctors are early recipients of KFDA approval to study psilocybin in South Korea. We believe the scientists, doctors and researchers involved in Kaiyon are amongst the best in the world and they will be studying at Kaiyon's Bio-lab. We cannot be happier with this arrangement between the Company, Kaiyon, and Pervasip Corp. We believe we have amassed a world-class group of professionals for studying the positive effects of psilocybin."
A royalty agreement is being negotiated by the team and will be announced shortly.
About Here To Serve Holding Corp.
Here to Serve Holding Corp. is a holding company that hunts for undervalued assets and accepts shares of common stock as a fee for its corporate advisory, SEC compliance, consulting, and marketing services. Run by an experienced team of professionals with diverse backgrounds, the Company formed two wholly owned subsidiaries, ICF Industries Inc. and Fortune Nickel and Gold Inc. ICF provides the advisory services to other companies and Fortune is dedicated to the global acquisition, exploration, and development of mining properties in prolific jurisdictions. Fortune recently acquired mining projects known as the Gowan and Beck-Ottaway properties located in the Timmins mining camp in Ontario, Canada. The Timmins mining camp lies at the heart of the Abitibi greenstone belt, which contains some of the world's largest deposits of gold, silver, copper, zinc, nickel, platinum-group metals, and industrial minerals such as talc. Fortune believes its projects have substantial gold and nickel potential.
For more information:
Please call Investor Relations with any questions at 855-4NICKEL (855-464-2535) extension 1.
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Pervasip Corp. Purchases Five Percent Interest in Kaiyon Biotech Inc.
Press Release | 06/16/2021
Granada Hills, California--(Newsfile Corp. - June 16, 2021) - Pervasip Corp. (OTC Pink: PVSP) (the "Company") is pleased to announce that it has purchased a five percent (5%) non-dilutive interest in Kaiyon Biotech Inc. ("Kaiyon").
Kaiyon is a collaboration of doctors, scientists, researchers and chemists that work to create new medicines using psilocybin and CBD compounds. The biotech team at Kaiyon believes that existing psilocybin research presents a pressing case for psilocybin to be an effective treatment for depression, pain, and drug addiction. It plans to expand on that research and support a hot bed of innovation for safe and productive drug use.
The Company applauds the newly formed Psilocybin Advisory Board formed in Oregon, and Oregon's efforts to build a support infrastructure through which psilocybin can be introduced to daily living via therapeutic use and licensed facilities.
The Company intends to leverage doctors and trained professionals in South Korea via its ownership in Kaiyon and bring the experience and training back to the United States. The acquisition requires the Company to issue 50 million restricted shares of common stock.
About Pervasip Corp.
Pervasip Corp. is a developer of companies and technologies in high value emerging markets. Pervasip is currently pursuing the acquisition of Artizen Corporation, which generates revenues by providing leasing, licensing, management, staffing, and supplies to cannabis production facilities.
Please email Investor Relations with any questions at info@pervasip.net or call 855-464-2535 extension 1.
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements include those that use forward-looking terminology, such as the words "anticipate," "believe," "estimate," "expect," "intend," "may," "hope'" "project," "plan," "will," "shall," "should," and similar expressions, including when used in the negative. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
$PVSP,NEWS coming per company tweet. DD Page: https://www.privateequitymarkets.us/pervasip-corp-otcpvsp
$PVSP, NEWS rumored from an excellent source. Last trade .0031. PT .50. Major acquisition coming imho.
DD:
http://transcendenceagecorp.com
$PVSP, NEWS rumored from an excellent source. Last trade .0031. PT .50. Major acquisition coming imho.
DD:
http://transcendenceagecorp.com
$HTSC, Breakout imminent. Starting to run. The stock moves quick as it busts through .12. .06 per share earnings. Nickel Sulphide EV play. Last trade .1245, up 15%.
DD:
http://heretoserve.tech
http://fortunenickelandgold.com
https://privateequitymarkets.us/here-to-serve-holding-corp-otchtsc
$HTSC, Breakout imminent. Starting to run. The stock moves quick as it busts through .12. .06 per share earnings. Nickel Sulphide EV play. Last trade .1245, up 15%.
DD:
http://heretoserve.tech
http://fortunenickelandgold.com
https://privateequitymarkets.us/here-to-serve-holding-corp-otchtsc
$HTSC, Breakout imminent. Starting to run. The stock moves quick as it busts through .12. .06 per share earnings. Nickel Sulphide EV play. Last trade .1245, up 15%.
DD:
http://heretoserve.tech
http://fortunenickelandgold.com
https://privateequitymarkets.us/here-to-serve-holding-corp-otchtsc
$HTSC, Only 19.9 milly in the DTC. DD: https://privateequitymarkets.us/here-to-serve-holding-corp-otchtsc
$HTSC, Only 19.9 milly in the DTC. DD: https://privateequitymarkets.us/here-to-serve-holding-corp-otchtsc
$PVSP, Asian Mind Med. Looking for a huge Valuation for PVSP. .0033-.50 is possible. DD : http://transcendenceagecorp.com
$PVSP, Asian Mind Med. Looking for a huge Valuation for PVSP. .0033-.50 is possible. DD : http://transcendenceagecorp.com
$HTSC, Huge EV Nickel sulphide and gold play. Also finds undervalued assets. Only 19.9 milly in the DTC. DD It:
http://fortunenickelandgold.com
http://heretoserve.tech
$HTSC, Huge EV Nickel sulphide and gold play. Also finds undervalued assets. Only 19.9 milly in the DTC. DD It:
http://fortunenickelandgold.com
http://heretoserve.tech
$HTSC, Huge EV Nickel sulphide and gold play. Also finds undervalued assets. Only 19.9 milly in the DTC. DD It:
http://fortunenickelandgold.com
http://heretoserve.tech
$HTSC, Diversified Industrial conglomerate being born right in front of our eyes. Last trade .1051. PT 2.00. DD:
https://privateequitymarkets.us/here-to-serve-holding-corp-otchtsc
http://fortunenickelandgold.com
http://heretoserve.tech
$HTSC, Diversified Industrial conglomerate being born right in front of our eyes. Last trade .1051. PT 2.00. DD:
https://privateequitymarkets.us/here-to-serve-holding-corp-otchtsc
http://fortunenickelandgold.com
http://heretoserve.tech
$HTSC, EV Battery play. Last trade .11 with only 19 million in the DTC. DD : https://privateequitymarkets.us/here-to-serve-holding-corp-otchtsc
$HTSC, EV Battery play. Last trade .11 with only 19 million in the DTC. DD : https://privateequitymarkets.us/here-to-serve-holding-corp-otchtsc
$PVSP, Last trade .0058. Psilocybin and International CBD. DD:
https://www.privateequitymarkets.us/pervasip-corp-otcpvsp
$PVSP, Last trade .0058. Psilocybin and International CBD. DD:
https://www.privateequitymarkets.us/pervasip-corp-otcpvsp
$PVSP, Last trade .0058. Psilocybin and International CBD. DD: https://www.privateequitymarkets.us/pervasip-corp-otcpvsp
$PVSP, Last trade .0058. Psilocybin and International CBD. DD: https://www.privateequitymarkets.us/pervasip-corp-otcpvsp
PVSP, Major runner in the making. International CBD and Psilocybin mushrooms. Last trade .0056. PT .50. Next Mind Med:
https://www.privateequitymarkets.us/pervasip-corp-otcpvsp
PVSP, Major runner in the making. International CBD and Psilocybin mushrooms. Last trade .0056. PT .50. Next Mind Med: https://www.privateequitymarkets.us/pervasip-corp-otcpvsp
$HTSC Last trade .1097. EV Battery play:
https://privateequitymarkets.us/here-to-serve-holding-corp-otchtsc
$PVSP Last trade .0055. Psilocybin and International CBD play: https://privateequitymarkets.us/pervasip-corp-otcpvsp
$HTSC Last trade .1097. EV Battery play: https://privateequitymarkets.us/here-to-serve-holding-corp-otchtsc
$PVSP Last trade .0055. Psilocybin and International CBD play: https://privateequitymarkets.us/pervasip-corp-otcpvsp
$HTSC Last trade .1097. EV Battery play: https://privateequitymarkets.us/here-to-serve-holding-corp-otchtsc
$PVSP Last trade .0055. Psilocybin and International CBD play: https://privateequitymarkets.us/pervasip-corp-otcpvsp